The Russian pharmaceutical company NovaMedica has announced the production and market launch of the first large batch of the drug Relonova® intended for relief of migraine-associated headaches.
The resident of SEZ Technopolis Moscow plans to complete the construction of a new large pharmaceutical production at Alabushevo site this year. The enterprise...